Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis

NCT00085644 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)

NCT00478660 ·Status: COMPLETED ·Phase: PHASE3

Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)

NCT01064856 ·Status: COMPLETED ·Phase: PHASE3

Optimization of Treatment With Adalimumab (Humira)

NCT01585064 ·Status: COMPLETED

Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)

NCT01329380 ·Status: COMPLETED

Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis

NCT00195819 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

NCT01078090 ·Status: COMPLETED

Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis

NCT01076205 ·Status: COMPLETED

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

NCT01346488 ·Status: COMPLETED

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

NCT00234897 ·Status: COMPLETED ·Phase: PHASE4

Study of Adalimumab in Patients With Axial Spondyloarthritis

NCT00939003 ·Status: COMPLETED ·Phase: PHASE3

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

NCT02456363 ·Status: UNKNOWN ·Phase: PHASE2

Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab

NCT01273519 ·Status: COMPLETED

Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

NCT01163318 ·Status: COMPLETED

Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients

NCT02333383 ·Status: COMPLETED

Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab

NCT01282372 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis

NCT01114880 ·Status: COMPLETED ·Phase: PHASE3

Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

NCT02322723 ·Status: WITHDRAWN

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis

NCT02634541 ·Status: UNKNOWN ·Phase: PHASE4

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

NCT00646178 ·Status: COMPLETED ·Phase: PHASE3

Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis

NCT01808118 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Humira in Behcet Patients With Arthritis

NCT01497717 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis Treated Concomitantly With Methotrexate.

NCT00195702 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

NCT04169373 ·Status: COMPLETED ·Phase: PHASE3